Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.68B
| $4.08M | ﹤0.01% |
100,000
-2,952,000
| -97% | -$121M |
|
2202
Sensata Technologies
ST
$6.73B
| $4.08M | ﹤0.01% |
90,744
-72,694
| -44% | -$3.19M |
|
|
RMM
2203
RiverNorth Managed Duration Municipal Income Fund
RMM
$285M
| $4.07M | ﹤0.01% |
268,989
+25,473
| +10% | +$388K |
|
2204
Natera
NTRA
$44.7B
| $4.07M | ﹤0.01% |
83,598
-11,025
| -12% | -$562K |
|
2205
iShares MSCI South Africa ETF
EZA
$560M
| $4.07M | ﹤0.01% |
102,174
+60,602
| +146% | +$2.47M |
|
2206
Invesco S&P SmallCap Health Care ETF
PSCH
$173M
| $4.05M | ﹤0.01% |
91,221
+32,523
| +55% | +$1.44M |
|
2207
PUT
Booking.com
BKNG
$159B
| $4.05M | ﹤0.01% |
37,500
| – | – |
|
2208
Popular Inc
BPOP
$11.3B
| $4.04M | ﹤0.01% |
66,827
-15,564
| -19% | -$917K |
|
2209
Crown Holdings
CCK
$12.9B
| $4.04M | ﹤0.01% |
46,561
-16,169
| -26% | -$1.33M |
|
2210
CALL
Crown Castle
CCI
$32.3B
| $4.03M | ﹤0.01% |
+35,400
| New | +$4.21M |
|
2211
BlackRock Health Sciences Trust II
BMEZ
$1B
| $4.03M | ﹤0.01% |
245,299
-11,681
| -5% | -$190K |
|
|
AMED
2212
DELISTED
Amedisys
AMED
| $4.02M | ﹤0.01% |
44,002
+5,374
| +14% | +$441K |
|
2213
CALL
Idexx Laboratories
IDXX
$43.4B
| $4.02M | ﹤0.01% |
+8,000
| New | +$3.83M |
|
|
2214
PUT
Idexx Laboratories
IDXX
$43.4B
| $4.02M | ﹤0.01% |
+8,000
| New | +$3.83M |
|
|
IBMN
2215
DELISTED
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
| $4.01M | ﹤0.01% |
152,219
-692
| -0.5% | -$18.2K |
|
2216
ABM Industries
ABM
$2.82B
| $4.01M | ﹤0.01% |
93,997
-2,013
| -2% | -$87.2K |
|
2217
Dimensional International High Profitability ETF
DIHP
$6.59B
| $4M | ﹤0.01% |
163,563
+149,020
| +1,025% | +$3.63M |
|
2218
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.98B
| $4M | ﹤0.01% |
84,736
+9,566
| +13% | +$456K |
|
|
XYZ
2219
PUT
Block Inc
XYZ
$49.8B
| $3.99M | ﹤0.01% |
60,000
-360,100
| -86% | -$22.5M |
|
|
EOS
2220
Eaton Vance Enhance Equity Income Fund II
EOS
$1.17B
| $3.98M | ﹤0.01% |
222,612
+2,718
| +1% | +$45.3K |
|
2221
Array Technologies
ARRY
$778M
| $3.98M | ﹤0.01% |
176,220
+16,164
| +10% | +$346K |
|
2222
BlackRock Health Sciences Trust
BME
$570M
| $3.98M | ﹤0.01% |
97,907
+2,110
| +2% | +$86.8K |
|
2223
Roku
ROKU
$23.4B
| $3.98M | ﹤0.01% |
62,187
+557
| +0.9% | +$33.8K |
|
2224
CALL
Target
TGT
$70.2B
| $3.97M | ﹤0.01% |
+30,100
| New | +$4.47M |
|
|
XIFR
2225
CALL
XPLR Infrastructure LP
XIFR
$1.11B
| $3.96M | ﹤0.01% |
67,500
+37,500
| +125% | +$2.26M |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.